Lantheus Holdings, Inc. (LNTH)

NASDAQ: LNTH · USD

$100

-0.04 (-0.0%)· Recorded snapshot

Market cap	6.5B
Revenue (ttm)	1.6B
Net income (ttm)	275.3M
EPS (ttm)	$4.15
Shares out	65.3M
P/E (trailing)	24.1x
P/E (forward)	17.6x
Volume	1,206,212
Beta	-0.06

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.6B
Net income (ttm): 275.3M
EPS (ttm): $4.15
P/E (trailing): 24.1x
P/E (forward): 17.6x
Market cap: 6.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.6

P25 n/aP50 n/aP75 n/a

Trailing P/E24.1

P25 n/aP50 n/aP75 n/a

ROE22.2

P25 n/aP50 n/aP75 n/a

ROIC17.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LNTH indicators

Market & fundamental data

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001521036
Company name	Lantheus Holdings, Inc.
Country	United States
Country code	US
CUSIP number	516544103
Earnings date	2026-11-09
Earnings time	bmo
Employees	1,193
Employees change	385
Employees growth	47.65%
Enterprise value	$6.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1956
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2015-06-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US5165441032
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$6.5B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$100.11
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	LNTH
U.S. state	Massachusetts
Website	https://www.lantheus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	16.83x
Average P/E ratio (10Y)	98.13x
Average P/E ratio (3Y)	20.79x
Average P/E ratio (5Y)	45.56x
Earnings yield	4.15%
EV/Earnings	23.85x
EV/EBIT	21.61x
EV/EBITDA	16.74x
EV/FCF	16.93x
EV/Sales	4.22x
FCF / EV yield	5.91%
FCF yield	5.94%
Forward EV/Sales	4.3x
Forward P/E	17.57x
Forward P/S	4.28x
Graham number	43.33511
Graham upside	-56.7%
Industry forward P/E	13.87x
Industry P/E	173.94x
Lynch fair value	$103.81
Lynch upside	3.72%
P/(FCF - SBC) ratio	21.09x
P/(OCF - SBC) ratio	19.52x
P/B ratio	4.98x
P/E ratio	24.11x
P/FCF ratio	16.85x
P/OCF ratio	15.83x
P/S ratio	4.2x
PEG ratio	1.2x
Price / tangible book value	17.04x
Price/EBITDA ratio	16.66x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.52%
EBITDA margin	25.2%
Effective tax rate	24.15%
FCF margin	24.92%
Gross margin	60.14%
Operating margin	19.52%
Pretax margin	23.32%
Profit margin	17.69%
Profit per employee	$230,767
Profitable quarters	6
Profitable years	4
Revenue per employee	$1.3M
ROA	8.38%
ROA (5Y)	7.5%
ROCE	14.61%
ROE	22.21%
ROE (5Y)	19.52%
ROIC	17.17%
ROIC (5Y)	20.72%
SBC / revenue	5.02%
Tax / revenue	5.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	10.07%
EPS growth (Q)	-0.89%
EPS growth (QoQ)	-38.33%
EPS growth 10Y	16.68%
EPS growth 3Y	104.89%
EPS growth years	0
FCF growth	-10.14%
FCF growth (Q)	13.55%
FCF growth (QoQ)	-26.28%
FCF growth 5Y	64.56%
Gross profit growth	-3.44%
Gross profit growth (Q)	0.35%
Gross profit growth 3Y	9.31%
Gross profit growth 5Y	42.01%
Net income growth	1.59%
Net income growth (Q)	-4.73%
Net income growth (QoQ)	-36.64%
Net income growth 3Y	102.06%
Net income growth years	0
OCF growth	-21.74%
OCF growth (Q)	5.85%
OCF growth (QoQ)	-26.31%
OCF growth 10Y	26.46%
OCF growth 3Y	14.48%
OCF growth 5Y	55.9%
Operating income growth	-29.82%
Operating income growth (Q)	13.92%
Operating income growth 3Y	24.37%
Revenue growth	2.35%
Revenue growth (Q)	2.68%
Revenue growth (QoQ)	2.87%
Revenue growth 10Y	17.9%
Revenue growth 3Y	11.43%
Revenue growth 5Y	32.84%
Revenue growth quarters	4
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-25M
Depreciation and amortization	$88.5M
EBIT	$303.7M
EBITDA	$392.2M
EPS	$4.15
FCF per share	$5.94
Financing cash flow	$-207.1M
Free cash flow	$387.8M
Free cash flow minus SBC	$309.7M
Gross profit	$936M
Income taxes	$87.7M
Investing cash flow	$-307M
Net borrowing	$-1.1M
Net cash flow	$-102.2M
Net income	$275.3M
Operating cash flow minus SBC	$334.7M
Operating income	$303.7M
Revenue	$1.6B
Stock-based compensation	$78.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.48
Book value per share	$20.10
Debt / EBITDA	1.57
Debt / equity	0.48
Debt / FCF	1.61
Goodwill	$239.1M
Interest coverage	15.33
Long-term assets	$1.4B
Long-term liabilities	$767.2M
Net cash (debt)	$-31.7M
Net cash / market cap	-0.48%
Net debt / EBITDA	0.08
Net debt / equity	0.02
Net debt / FCF	0.08
Piotroski F-Score	4
Property, plant and equipment	$153.3M
Shareholders' equity	$1.3B
Tangible book value	$383.4M
Tangible book value per share	$5.87
Total assets	$2.4B
Total cash	$593.3M
Total debt	$625M
Total liabilities	$1.1B
WACC	3.8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.69
Current assets	$1B
Current liabilities	$335.7M
Current ratio	3.06
Inventory turnover	10.36
Net working capital	$98.8M
Quick ratio	2.82
Working capital	$691.4M
Working capital turnover	1.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.97%
Dividend yield	0%
Shareholder yield	7.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	1,090.95%
10Y return CAGR	28.12%
10Y total return	1,090.95%
150-day SMA	$97.37
1D price change	-0.04%
1M price change	0.3%
1M total return	0.3%
1W price change	-0.35%
1W total return	-0.35%
1Y price change	72.1%
1Y return CAGR	72.16%
1Y total return	72.1%
20-day SMA	$100.03
200-day SMA	$91.03
3M price change	-7.4%
3M total return	-7.4%
3Y price change	49.69%
3Y return CAGR	14.39%
3Y total return	49.69%
50-day SMA	$100.26
50-day SMA vs 200-day SMA	50over200
52-week high	$111.86
52-week high date	2026-06-30
52-week low	$50.16
52-week low date	2025-11-10
5Y price change	343.83%
5Y return CAGR	34.73%
5Y total return	343.83%
6M price change	18.94%
6M total return	18.94%
All-time high	$126.89
All-time high date	2024-07-16
All-time low	$1.76
All-time low date	2016-02-10
Average true range (ATR)	$0.43
Average volume	974.3K
Beta (1Y)	0.52
Beta (2Y)	0.35
Beta (5Y)	-0.06
Change from 52-week high	-10.5%
Change from 52-week low	99.6%
Change from all-time high	-21.16%
Change from all-time low	5,584.09%
Change from open	0.04%
Day's gap	-0.08%
Dollar volume	$120.8M
High price	$100.21
Low price	$99.98
Monthly RSI	59.12
Open price	$100.07
Position in 52-week range	56.52%
Premarket change	0.1%
Premarket close	$100.15
Premarket price	$100.25
Premarket volume	3.6K
Previous close	$100.15
Price vs 150-day SMA	2.74%
Price vs 20-day SMA	0.01%
Price vs 200-day SMA	9.89%
Price vs 50-day SMA	-0.22%
Relative volume	1.24
RSI	48.49
Sharpe ratio	1.72
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	0.73
Sortino ratio	3.14
Sortino ratio (3Y)	0.74
Sortino ratio (5Y)	1.23
Volume	1.2M
Weekly RSI	59.5
YTD price change	50.32%
YTD total return	50.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.6M
Float percentage	89.8%
Shares change (QoQ)	2.65%
Shares change (YoY)	-7.97%
Shares held by insiders	1.6%
Shares held by institutions	106.99%
Shares outstanding	65.3M
Short % of float	6.2%
Short % of shares	5.56%
Short ratio	3.7 days

Deeper analysis on LNTH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LNTH report

Is a complete LNTH research report available?

No complete published report is available for Lantheus Holdings, Inc. (LNTH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lantheus Holdings, Inc. (LNTH)

Price

Financial snapshot

Fair-value bridge

Latest news · LNTH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LNTH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LNTH

Frequently asked questions